New Delhi-based Alniche Lifesciences, one of the leading and fastest-growing pharma companies in India, has announced the expansion of its footprints in respiratory care to expand its reach and impact.

The upcoming portfolio of new respiratory products aims to provide effective solutions for a range of respiratory conditions.

"At Alniche, we are constantly striving to improve patient outcomes and healthcare delivery. We are excited to expand our critical care portfolio and provide innovative solutions that address unmet needs in respiratory," said Girish Arora, Founder & MD - Alniche Lifesciences.

“Alniche's commitment to respiratory health is rooted in its mission to deliver high-quality, innovative healthcare solutions to patients all over India. As we expand our footprint in the respiratory segment, we look forward to working with healthcare providers, patient advocacy groups, and other stakeholders to improve patient outcomes and advance healthcare,” added Girish Arora.